Summary: Patients with OSA who used CPAP therapy before total hip and knee replacement surgeries had significantly fewer complications post-surgery compared to those who didn’t use CPAP, finds a study conducted by the Hospital for Special Surgery. In a study presented by the Hospital for Special Surgery at the 14th annual meeting of the Society…
I love Romans chapter 8. If you’re a Christian, I imagine you love it too. What Paul so beautifully describes rings with a hope we recognize, a hope that resonates deep within our souls and stirs longing for our far-off homeland, our heavenly one. In Romans 8, we catch glimpses of “the glory that is…
Transcript SUSAN AMARA: Thanks, Dan. And I also want to thank the panelists and previous speakers for providing such a compelling and exciting vision of the future. I think it’s given me a lot of optimism for the future. So, thank you all. I’m Susan Amara. And I’m the scientific director at NIMH.And it’s really…
Transcript DANIEL HANDWERKER: Good afternoon and welcome back from your break. My name is Dan Handwerker, and I’m a staff scientist in the section on functional imaging methods in NIMH’s Intramural Research Program. And it is my pleasure to introduce our next group of speakers.Jahn Jaramillo is a doctoral candidate in the Division of Preventative…
Sleep tech startup PranaQ has received a strategic investment from DelightRoom, a global tech company focused on morning wellness and the developer of the Alarmy alarm app. The strategic partnership will help PranaQ drive market adoption of its sleep-tracking wearable by leveraging DelightRoom’s direct-to-consumer capabilities and enable Delightroom to enhance Alarmy’s morning wellness offerings by…
Transcript SERENA CHU: Welcome back, everyone. If you could take your seats, we’re — I’m going to go ahead and get started. Good afternoon. My name is Serena Chu, and I am a scientific review officer in the Division of Extramural Activities. And it is my great pleasure to introduce the speakers to you today.We…
Summary: The FDA has approved Avadel Pharmaceuticals’ LUMRYZ for pediatric patients aged 7 and older with narcolepsy, offering a once-nightly treatment for cataplexy and excessive daytime sleepiness. Key Takeaways: FDA Approval for Pediatric Use: LUMRYZ, previously approved for adults, is now FDA-approved for children aged 7 and older with narcolepsy, offering a once-nightly treatment for…
Transcript MAURA LANDERS: Thank you, Dr. Bellamy, for your inspiring presentation. Can I just get another round of applause? Because she really took the theme and very inspiring. So, thank you. My name is Maura Landers. I am a program analyst in the NIMH Office of Science — oh gosh, Policy Planning and Communications. And I…
Transcript FEMALE SPEAKER: Thank you for joining us for the National Institute of Mental Health’s third and final 75th anniversary celebration, our symposium, Inspiration and Aspiration: Future Perspectives in Mental Health Research, here at the National Archives Building.Today’s seating is open, but we do ask if you could please fill the seats down front and…